Bluejay Diagnostics, Inc. (BJDX)

Bluejay Diagnostics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	2.21	10.11	19.05	0.91	0.1
Cash & Cash Equivalents	2.21	10.11	19.05	0.91	0.1
Cash Growth	-78.17%	-46.90%	1987.75%	850.27%	-
Receivables	0	0	0	0	0
Inventory	0	0	0	0.08	0.12
Other Current Assets	1.01	1.67	1.61	0.06	0.08
Total Current Assets	3.22	11.79	20.66	1.06	0.3
Property, Plant & Equipment	1.62	1.7	0.34	0.46	0.62
Other Long-Term Assets	0.03	0.04	0.02	0	0
Total Long-Term Assets	1.65	1.73	0.36	0.46	0.62
Total Assets	4.87	13.52	21.02	1.52	0.92
Accounts Payable	0.49	0.64	0.3	0.5	0.12
Current Debt	0.16	0.17	0	1.06	0.27
Other Current Liabilities	1.12	0.84	0.34	0.29	0.2
Total Current Liabilities	1.77	1.64	0.64	1.85	0.58
Long-Term Debt	0.19	0.32	0	0	0.8
Other Long-Term Liabilities	0.01	0.02	0	0	0
Total Long-Term Liabilities	0.2	0.34	0	0	0.8
Total Liabilities	1.97	1.98	0.64	1.85	1.38
Total Debt	0.35	0.49	0	1.06	1.07
Debt Growth	-28.35%	-	-	-1.25%	-
Retained Earnings	-26.95	-17	-7.69	-4.21	-2.93
Shareholders' Equity	2.89	11.54	20.38	-4.21	-2.93
Net Cash / Debt	1.86	9.62	19.05	-0.14	-0.97
Net Cash / Debt Growth	-80.72%	-49.48%	-	-	-
Net Cash Per Share	1.69	9.54	44.70	-0.91	-6.19
Working Capital	1.45	10.15	20.02	-0.79	-0.28
Book Value Per Share	2.64	11.45	47.83	-26.73	-18.64

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).